Conferences Rigel Pharmaceuticals is attending in 2026–2027
Rigel Pharmaceuticals is listed at 4 conferences on Tnuki's calendar in 2026–2027: SABCS 2026 (exhibiting), ASH 2026 (exhibiting), ASCO 2027 (exhibiting) and World CDx 2026 (on the program). Rigel Pharmaceuticals is a biopharmaceutical company developing medicines for hematologic disorders, cancer, and immune-mediated diseases. As of Nov 12, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
San Antonio Breast Cancer Symposium 2026Breast cancer clinicians & researchersOfficial site |
San Antonio, TX ~11k attendees | ExhibitorAs published by SABCS (UT Health San Antonio, AACR) Booth 1311
|
Open the guide Search and filter attendees |
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site |
New Orleans, LA ~30k attendees | ExhibitorAs published by American Society of Hematology Booth 613Program 2 symposia
|
Open the guide Search and filter attendees |
ASCO Annual Meeting 2027World’s largest clinical oncology meetingOfficial site |
Chicago, IL ~44k attendees | ExhibitorAs published by American Society of Clinical Oncology Booth 30121
|
Open the guide Search and filter attendees |
16th World Clinical Biomarkers & Companion Diagnostics SummitCompanion diagnostics & clinical biomarker leadsOfficial site |
Past Boston, MA ~900 attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 panel discussionAttending Senior Vice President, Managed Markets & Access Strategy
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 66 of the 162 conferences on our calendar, so this page shows Rigel Pharmaceuticals’s involvement at those 66 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.